crushes topiramate in chronic migraine PRO benefits, antiamyloid antibody slowed Alzheimer’s progression while also clearing brain amyloid, and the USPSTF says that nontraditional CVD risk factors are not ready for primetime. Listen to the MDedge Daily News for today’s top news. Also today, OnabutolinumtoxinA